A number of companies are using the lessons and technologies of traditional genomics--the microarray chief among them--to delve into the more challenging world of functional genomics and proteomics.
Integrating high-throughput proteomics into pharmaceutical R&D has shifted how laboratories approach target identification and disease modeling. Mapping complex protein networks provides a functional ...
InvestorsHub on MSN
Aditxt acquires Ignite Proteomics to expand precision oncology capabilities
Aditxt Inc. (NASDAQ:ADTX) announced it has acquired Ignite Proteomics LLC, a precision oncology company specializing in functional proteomics technology used to guide cancer treatment decisions, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results